European Medicines Agency Archives -

NICE has a global reputation as a pioneering HTA – but is that influence at risk now that

How will NICE fare in a post-Brexit world?

https://pharmaphorum.com/views-analysis-market-access/how-will-nice-fare-in-a-post-brexit-world/

Coronavirus could threaten US drug supplies – report

Richard Staines coronavirus, COVID-19, European Medicines Agency, fda, infectious diseases, President Trump 0 Comment

About 150 prescription drugs, including antibiotics, generics and some branded drugs without alternatives, could be at risk of

Coronavirus could threaten US drug supplies – report

https://pharmaphorum.com/news/coronavirus-could-threaten-us-drug-supplies-report/

Brexit/ News/ UK & Europe

EMA cuts services amid Brexit staff exodus

Richard Staines Brexit, EMA relocation, European Medicines Agency 0 Comment

Europe’s medicines regulator has said it is temporarily cutting services as it will lose at least 30% of

EMA cuts services amid Brexit staff exodus

https://pharmaphorum.com/news/ema-cuts-services-amid-brexit-staff-exodus/

News/ News/ R&D/ Roche/ Top pharmaceutical companies/ UK & Europe

New Huntington’s drug granted priority designation

Joy Persaud European Medicines Agency, Huntington's disease, Roche 0 Comment

Roche’s treatment for Huntington’s disease has received a priority designation by the European regulator, sparking hope that a

New Huntington’s drug granted priority designation

https://pharmaphorum.com/news/huntingtons-drug-granted-priority-designation/

Brexit/ News

MPs call for UK to remain in EMA after Brexit

Richard Staines Brexit, European Medicines Agency 0 Comment

The government must prioritise remaining a member of the European Medicines Agency in Brexit negotiations, after a key

MPs call for UK to remain in EMA after Brexit

https://pharmaphorum.com/news/mps-call-for-uk-to-remain-in-ema-after-brexit/

Brexit/ News/ UK & Europe

UK pharma welcomes May’s Brexit plan

Richard Staines Brexit, European Medicines Agency, regulation 0 Comment

Proposals finally outlined in White Paper

UK pharma welcomes May’s Brexit plan

https://pharmaphorum.com/news/uk-pharma-welcomes-mays-brexit-plan/

News/ News/ Patients/ Top stories

Blood pressure drug recalled on cancer fears

Piotr Wnuk European Medicines Agency, Valsartan 0 Comment

Valsartan, a drug widely used to control blood pressure is being recalled in several countries around the world

Blood pressure drug recalled on cancer fears

https://pharmaphorum.com/news/valsartan-recalled-cancer-fears/

bicycle rider on cobblestone bridge in afternoon sunlight, Amsterdam

Healthcare/ News/ Top stories/ UK & Europe

Amsterdam will minimise disruption – but no EMA guarantee on approvals

Andrew McConaghie EMA relocation, European Medicines Agency, Pharma regulation 0 Comment

Amsterdam chosen as the new home of the European Medicines Agency.

Amsterdam will minimise disruption – but no EMA guarantee on approvals

https://pharmaphorum.com/news/amsterdam-will-minimise-ema-disruption-no-guarantees-approvals/

Market Access/ News/ News/ UK & Europe

EMA spends in anticipation of Brexit staff losses

Richard Staines Brexit, European Medicines Agency, regulation 0 Comment

Europe’s drugs regulator has issued a temporary staffing contract worth up to £32 million, in order to ensure

EMA spends in anticipation of Brexit staff losses

https://pharmaphorum.com/news/ema-covers-staffing-gap-brexit-move/

Trending

European Medicines Agency

Login